Status:
COMPLETED
Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients
Lead Sponsor:
Advanced Perfusion Diagnostics
Collaborating Sponsors:
CEISO
Conditions:
High-risk Surgical Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Circulatory shock is defined as an imbalance between oxygen supply and/or impaired oxygen use to maintain organ function. With growing evidence of lack of correlation between macro- and micro-circulat...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 18 years of age or more,
- Male or female,
- High-Risk surgical patient,
- Life expectancy expected to exceed 72 hours,
- Willing to participate and signed informed consent,
- Affiliation to the French social security system.
- Non inclusion criteria:
- Pregnant or lactating woman,
- History of recent urological surgery (bladder surgery, prostate surgery…),
- Known stricture or "impossible insertion" last hospitalization,
- Traumatic injury to the lower urinary tract,
- History of radiotherapy of pelvic or genital area,
- Genital malformation (Hypospadias…).
Exclusion
Key Trial Info
Start Date :
August 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03410069
Start Date
August 3 2018
End Date
May 7 2019
Last Update
May 20 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Estaing
Clermont-Ferrand, France, 63003
2
Lyon Sud Hospital
Lyon, France, 69310
3
Hopital Nord Marseille
Marseille, France, 13015
4
Hospital Saint Louis
Paris, France